Appointment of Chief Medical Officer

TriSalus Life Sciences, Inc. announced the appointment of Dr. Richard Marshall as Chief Medical Officer, effective June 29, 2026. Dr. Marshall, currently Medical Director, will lead the company's medical strategy. He brings extensive experience in interventional radiology and oncology. His compensation includes a base salary of $525,000, a $250,000 sign-on bonus, and potential bonuses and equity awards. The company also highlighted its Pressure-Enabled Drug Delivery (PEDD) platform and its investigational immunotherapy, nelitolimod, in the press release announcing Dr. Marshall's appointment. This appointment is part of the company's strategy to strengthen its leadership team and advance its PEDD platform for treating solid tumors.